Tumor-selective catalytic nanomedicine by nanocatalyst delivery.
about
Tumor Microenvironment-Enabled Nanotherapy.Targeted production of reactive oxygen species in mitochondria to overcome cancer drug resistance.Overcoming Ovarian Cancer Drug Resistance with a Cold Responsive Nanomaterial.Rationally designed upconversion nanoprobe for simultaneous highly sensitive ratiometric detection of fluoride ions and fluorosis theranosticsIron and magnetic: new research direction of the ferroptosis-based cancer therapy
P2860
Tumor-selective catalytic nanomedicine by nanocatalyst delivery.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
Tumor-selective catalytic nanomedicine by nanocatalyst delivery.
@en
type
label
Tumor-selective catalytic nanomedicine by nanocatalyst delivery.
@en
prefLabel
Tumor-selective catalytic nanomedicine by nanocatalyst delivery.
@en
P2860
P1476
Tumor-selective catalytic nanomedicine by nanocatalyst delivery
@en
P2093
Liying Wang
Minfeng Huo
P2860
P2888
P356
10.1038/S41467-017-00424-8
P407
P577
2017-08-25T00:00:00Z
P6179
1091298606